NL7904311A - Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten. - Google Patents

Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.

Info

Publication number
NL7904311A
NL7904311A NL7904311A NL7904311A NL7904311A NL 7904311 A NL7904311 A NL 7904311A NL 7904311 A NL7904311 A NL 7904311A NL 7904311 A NL7904311 A NL 7904311A NL 7904311 A NL7904311 A NL 7904311A
Authority
NL
Netherlands
Prior art keywords
derivatives
active component
pharmaceutical preparations
component containing
containing pharmaceutical
Prior art date
Application number
NL7904311A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NL7904311A publication Critical patent/NL7904311A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7904311A 1978-05-31 1979-05-31 Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten. NL7904311A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25575/78A GB1599740A (en) 1978-05-31 1978-05-31 Hydantoin derivatives

Publications (1)

Publication Number Publication Date
NL7904311A true NL7904311A (nl) 1979-12-04

Family

ID=10229898

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7904311A NL7904311A (nl) 1978-05-31 1979-05-31 Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.

Country Status (11)

Country Link
JP (1) JPS554371A (nl)
AU (1) AU4762579A (nl)
BE (1) BE876670R (nl)
DE (1) DE2922070A1 (nl)
FR (1) FR2427331A2 (nl)
GB (1) GB1599740A (nl)
IL (1) IL57436A0 (nl)
IT (1) IT1164693B (nl)
NL (1) NL7904311A (nl)
SE (1) SE7904700L (nl)
ZA (1) ZA787354B (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
JPS55151569A (en) * 1979-05-09 1980-11-26 Wellcome Found Optically active heterocyclic compounds* their synthesis and medical blend containing them
EP0023083A1 (en) * 1979-06-27 1981-01-28 Beecham Group Plc Oxodiazole derivatives, processes for their production and pharmaceutical composition containing them
US4908456A (en) * 1989-04-05 1990-03-13 Takatori Corporation Process for preparing methylolated hydantoins
CN1084792C (zh) * 1999-05-31 2002-05-15 宝山钢铁股份有限公司 高风温高炉热风炉空气、煤气预热方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1176261A (en) * 1976-06-03 1984-10-16 Albert G. Caldwell Hydantoin derivatives
DK391678A (da) * 1977-09-05 1979-03-06 Wellcome Found Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse

Also Published As

Publication number Publication date
AU4762579A (en) 1979-11-22
SE7904700L (sv) 1979-12-01
IT1164693B (it) 1987-04-15
DE2922070A1 (de) 1979-12-06
FR2427331A2 (fr) 1979-12-28
GB1599740A (en) 1981-10-07
JPS554371A (en) 1980-01-12
IL57436A0 (en) 1979-09-30
ZA787354B (en) 1980-08-27
BE876670R (fr) 1979-11-30
FR2427331B2 (nl) 1983-01-28
IT7949253A0 (it) 1979-05-30

Similar Documents

Publication Publication Date Title
NL177749C (nl) N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten.
NL7907583A (nl) Heterocyclische verbindingen, in het bijzonder indool- verbindingen, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL8103768A (nl) Heterocyclische verbindingen, werkwijze ter bereiding daarvan, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL980013I2 (nl) Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
ATA464579A (de) Insektizidpraeparate
AU522796B2 (en) Pharmaceutical preparations containing urea or hydantoin derivatives
NL190519B (nl) 4-gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten.
NL7803195A (nl) Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten.
NL971008I2 (nl) Herbicide pyridinederivaten en deze derivaten bevattende herbicide preparaten.
DK116380A (da) Bradykninhaemmende tripeptidforbindelser fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NL188575C (nl) Triazolylacetofenonderivaten, geschikt als fungicide, alsmede dergelijke derivaten bevattende fungicide preparaten.
NL7706064A (nl) Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten.
NL7903650A (nl) Purinederivaten met bronchi verwijdende werking alsmede farmaceutische preparaten die deze verbinding als ac- tieve component bevatten.
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7903769A (nl) Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL7902726A (nl) Sulfonato-organosilanolverbindingen en preparaten, welke deze bevatten.
NL7904311A (nl) Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.
DK529879A (da) Galeniske praeparater indehldende ergotalkaloider
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
NL7810758A (nl) Gesubstitueerde 7 beta-amidino-delta3-cefem-4-carbon- zuren alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7803418A (nl) 15-deoxy-16-hydroxy-16-gesubstitueerde prostaan- zuren, werkwijzen ter bereiding daarvan alsmede farmaceutische preparaten, die deze verbindin- gen als actieve component bevatten.
MC1371A1 (fr) Preparations pharmaceutiques

Legal Events

Date Code Title Description
BV The patent application has lapsed